LIANG Zengcai, MA Caiyun, GUO Yu, ZHU Xiang, LU Taofeng, CHEN Liang, LI Qian
To investigate the ameliorative effect of matcha on the memory acquisition impairment model mice induced by scopolamine and its underlying mechanisms, C57BL/6 female mice were divided into 6 groups, namely the control group, the scopolamine group, the donepezil group (1.50 mg·kg-1), the low-dose matcha group (0.75 g·kg-1), the medium-dose matcha group (1.50 g·kg-1) and the high-dose matcha group (3.00 g·kg-1). On the 31st to 35th days after the injection, the memory acquisition impairment model was established by using scopolamine (5.00 mg·kg-1). The analysis was carried out through methods and techniques such as the Morris water maze test, the step-down test, the dark avoidance experiment, HE staining, enzyme-linked immunosorbent assay (ELISA) and Western blotting. The results demonstrate that matcha could, to a certain extent, improve the learning and memory abilities of the mice with memory acquisition impairment, inhibit the expression of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in the hippocampus tissue, enhance superoxide dismutase (SOD) in the hippocampus tissue, reduce malondialdehyde (MDA) content and glutathione peroxidase (GSH-Px) activity, and upregulate the expressions of Nrf2, SOD, GSH-ST and HO-1 proteins in hippocampal tissue. Meanwhile, it regulated choline metabolism and increased hippocampal choline content, thereby improving the cognitive dysfunction induced by scopolamine in mice. In conclusion, Guizhou-produced matcha plays a positive role in ameliorating memory impairment induced by scopolamine, and its mechanism may be related to enhancing anti-inflammatory activity, alleviating oxidative stress, and regulating neurotransmitters. This study enriched and improved the mechanism of matcha in ameliorating Alzheimer's disease and provided a research foundation and theoretical support for matcha-related health foods.